OPN was found to be upregulated in the serum of pancreatic cancer patients, plasma of ovarian cancer patients, plasma from multiple myeloma patients, and in tissues from bladder cancer biopsies [32,33,173,174,175]. Here, SPP1 is linked to plasma cell myeloma.